Confocal microscopy: innovative diagnostic tools for monitoring of noninvasive therapy in cutaneous malignancies

Drug Discovery Today: Disease Mechanisms

Volumn 5, Issue 1, 2008, Pages

  Astner, S ^a,d   Swindells, K ^d   Gonzalez S ^b,c,d   Stockfleth, E ^a   Lademann, J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; IMIQUIMOD;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; HUMAN; NON INVASIVE PROCEDURE; ORGAN TRANSPLANTATION; PHOTODYNAMIC THERAPY; REVIEW; SKIN CANCER; TREATMENT RESPONSE;

EID: 67349195737     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2008.04.002     Document Type: Review

References (51)

1. Euvrad S., et al. A comparative epidemiologic study of premalignant and malignant epithelial lesions developing after kidney and heart transplantion. J. Am. Acad. Dermatol. 33 (1995) 222-229
2. Espana A., et al. A prospective study of incident nonmelanoma skin cancer in heart transplant patients. J. Invest. Dermatol. 115 (2000) 1158-1160
3. Berg D., et al. Skin Cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J. Am. Acad. Dermatol. 47 (2002) 1-17
4. Ong C.S., et al. Skin cancer in Australian heart transplant recipients. J. Am. Acad. Dermatol. 40 (1999) 27-34
5. Hartevelt M., et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 49 (1999) 506-509
6. McLelland A., et al. The incidence of immunosuppression-related skin disease in long-term transplant patients. Transplantation 46 (1988) 871-874
7. Jensen P., et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J. Am. Acad. Dermatol. 40 (1999) 177-186
8. Ulrich M., et al. Optimization of evaluation parameters for the diagnosis of actinic keratoses by in vivo reflectance confocal microscopy. J. Dermatol. Surg. 34 (2008) 1-10
9. Ulrich M., et al. Noninvasive diagnostic tools for nonmelanoma skin cancer. Br. J. Dermatol. 157 Suppl 2 (2007) 56-58
10. Ulrich M., et al. Actinic keratoses: non-invasive diagnosis for field cancerisation. Br. J. Dermatol. 156 (2007) 13-17
11. Rajadhyaksha M., et al. In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast. J. Invest. Dermatol. 104 (1995) 946-952
12. Rajadhyaksha M., et al. Video-rate confocal scanning laser microscope for imaging human tissues in vivo. Appl. Optics 38 (1999) 1-12
13. Rajadhyaksha M., et al. In vivo confocal scanning laser microscopy of human skin II: advances in instrumentation and comparison with histology. J. Invest. Dermatol. 13 (1999) 293-303
14. Rajadhyaksha M., et al. Confocal examination of nonmelanoma cancers in thick skin excisions to potentially guide Mohs' micrographic surgery without frozen histopathology. J. Invest. Dermatol. 117 (2001) 1137-1143
15. Swindle L.D., et al. View of normal human skin in vivo as observed using fluorescent fiber-optic confocal microscopic imaging. J. Invest. Dermatol. 121 (2003) 706-712
16. Swindle L.D., et al. Fluorescence confocal microscopy of normal human skin and skin lesions in vivo. Skin Res. Tech. 9 (2003) 167
17. Boyde A., et al. Fluorescence in the tandem scanning microscope. J. Microsc. 157 (1990) 39-49
18. Caspers P.J., et al. In vivo confocal Raman microspectroscopy of the skin: noninvasive determination of molecular concentration profiles. J. Invest. Dermatol. 116 (2001) 434-442
19. Pierce M.C., et al. Advances in optical coherence tomography imaging for dermatology. J. Invest. Dermatol. 123 (2004) 458-463
20. Yaroslavsky A., et al. Fluorescence polarization imaging for delineating nonmelanoma skin cancers. Opt. Lett. 1 (2004) 2010-2012
21. Konig K., et al. Two-photon excited lifetime imaging of autofluorescence in cells during UVA and NIR photostress. J. Microsc. 183 (1996) 197-204
22. Aghassi D., et al. Confocal laser microscopic imaging of actinic keratoses in vivo: a preliminary report. J. Am. Acad. Dermatol. 43 (2000) 42-48
23. Nori S., et al. Sensitivity and Specificity of reflectance mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: a multicenter study. J. Am. Acad. Dermatol. 51 (2004) 923-930
24. Kennedy J.C., et al. Photodynamic therapy with endogenous protoporphyrin IX basic principles and present clinical experience. J. Photochem. Photobiol. B. 6 (1990) 143-148
25. Kurwa H.A., et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J. Am. Acad. Dermatol. 41 (1999) 414-418
26. Beutner K.R., et al. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob. Agents Chemother. 42 (1998) 789-794
27. Burns C.A., and Brown M.D. Imiquimod for the treatment of skin cancer. Dermatol. Clin. 23 (2005) 151-164
28. Szeimies R.M., et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J. Am. Acad. Dermatol. 51 (2004) 547-555
29. Geisse J.K., et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J. Am. Acad. Dermatol. 47 (2002) 390-398
30. Urosevic M., et al. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch. Dermatol. 139 (2003) 1325-1332
31. Barnetson R.S., et al. Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells. Clin. Exp. Dermatol. 29 (2004) 639-643
32. Miller R.L., et al. Imiquimod applied topically: a novel immune response modifier and a new class of drug. Int. J. Immunopharmacol. 21 (1999) 1-14
33. Lysa B., et al. Gene expression in actinic keratosis: pharmacological modulation by imiquimod. Br. J. Dermatol. 151 (2004) 1150-1159
34. Ooi T., et al. Imiquimod-included regression of actinic keratosis is associated with infiltration by T Lymphozytes and dendritic cells: a randomized controlled trial. Br. J. Dermatol. 154 (2006) 72-78
35. Callen J.P., et al. Actinic keratosis. J. Am. Acad. Dermatol. 36 (1997) 650-653
36. Lebwohl M., et al. Imiquimod 5% Cream for the treatment of actinic keratosis. Results from two phase III, randomized, double-blind, parallel group, vehicle controlled trials. J. Am. Acad. Dermatol. 50 (2004) 714-721
37. Swindells K., et al. Reflectance confocal microscopy may differentiate acute allergic and irritant contact dermatitis in vivo. J. Am. Acad. Dermatol. 50 (2004) 220-228
38. Astner S., et al. Non-invasive evaluation of the kinetics of allergic and irritant contact dermatitis. J. Invest. Dermatol. 124 (2005) 351-359
39. Middelkamp-Hup M.A., et al. Detection of UV-induced pigmentary and epidermal changes over time using in vivo reflectance confocal microscopy. J. Invest. Dermatol. 126 (2006) 402-407
40. Yamashita T., et al. The evaluation of the melanin and blood flow changes in UVA irradiated skin by reflectance-mode confocal microscopy. Exp. Dermatol. 16 (2001) 905-911
41. González S., et al. Real-time evidence of in vivo leukocyte trafficking in human skin by reflectance confocal microscopy. J. Invest. Dermatol. 117 (2001) 384-386
42. Lademann J., et al. Determination of the thickness and structure of the skin barrier by in vivo laser scanning microscopy. Laser Phys. Lett. 5 (2008) 311-315
43. Marra D., et al. Detection of residual basal cell carcinoma by in vivo confocal microscopy. Dermatol. Surg. 31 (2005) 538-541
44. Torres A., et al. 5% Imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs' micrographic surgery for treatment of basal cell carcinoma. Dermatol. Surg. 30 (2004) 1462-1469
45. Torres A., et al. Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream. J. Transl. Med. 5 (2007) 7
46. Alomar A., et al. Vehicle controlled, randomized double blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. Br. J. Dermatol. 157 (2007) 133-141
47. Curiel-Lewandrowski C., et al. Use of in vivo confocal microscopy in malignant melanoma. An aid in diagnosis and assessment of surgical and non-surgical therapeutic approaches. Arch. Dermatol. 140 (2004) 1127-1132
48. Wolf P., et al. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas. J. Am. Acad. Dermatol. 28 (1993) 17-21
49. Braakhuis B.J., et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 63 (2003) 1727-1730
50. Gerger A., et al. Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors. J. Invest. Dermatol. 124 (2005) 493-498
51. Astner S., et al. Clinical applicability of in-vivo fluorescence confocal microscopy for non-invasive diagnosis and therapeutic monitoring of non-melanoma skin cancer. J. Biomedical Optics 13 1 (2008) 014003